Literature DB >> 24958940

Topiramate: antipsychotic-induced weight gain.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2014        PMID: 24958940      PMCID: PMC4062746          DOI: 10.1310/hpj4904-345

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  11 in total

1.  Weight loss with topiramate.

Authors:  K H Littrell; R G Petty; N M Hiligoss; C D Peabody; C G Johnson
Journal:  Ann Pharmacother       Date:  2001-09       Impact factor: 3.154

2.  Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.

Authors:  K N Roy Chengappa; J Levine; D Rathore; H Parepally; R Atzert
Journal:  Eur Psychiatry       Date:  2001-04       Impact factor: 5.361

3.  Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review.

Authors:  Yasser Khazaal; Anne Chatton; Manon Rusca; Martin Preisig; Daniele Zullino
Journal:  Gen Hosp Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.238

Review 4.  Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents.

Authors:  Shamail Mahmood; Ian Booker; Judy Huang; Craig I Coleman
Journal:  J Clin Psychopharmacol       Date:  2013-02       Impact factor: 3.153

5.  Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

Authors:  Jess G Fiedorowicz; Del D Miller; Jeffrey R Bishop; Chadi A Calarge; Vicki L Ellingrod; William G Haynes
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

6.  Open-label adjunctive topiramate in the treatment of bipolar disorders.

Authors:  S L McElroy; T Suppes; P E Keck; M A Frye; K D Denicoff; L L Altshuler; E S Brown; W A Nolen; R W Kupka; J Rochussen; G S Leverich; R M Post
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

7.  Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation.

Authors:  Christoph Egger; Moritz Muehlbacher; Melanie Schatz; Marius Nickel
Journal:  J Clin Psychopharmacol       Date:  2007-10       Impact factor: 3.153

8.  Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

Authors:  Eduard Vieta; Jose Sánchez-Moreno; José Manuel Goikolea; Francesc Colom; Anabel Martínez-Arán; Antonio Benabarre; Bàrbara Corbella; Carla Torrent; Mercè Comes; María Reinares; Esteve Brugue
Journal:  J Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.153

9.  Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.

Authors:  H Afshar; H Roohafza; G Mousavi; S Golchin; N Toghianifar; M Sadeghi; M Talaei
Journal:  J Psychopharmacol       Date:  2008-05-30       Impact factor: 4.153

Review 10.  Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.

Authors:  Chandan Das; Guillermo Mendez; Sonal Jagasia; Lawrence A Labbate
Journal:  Ann Clin Psychiatry       Date:  2012-08       Impact factor: 1.567

View more
  2 in total

Review 1.  The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.

Authors:  Adonis Sfera; Carolina Osorio; Luzmin Acosta Inderias; Victoria Parker; Amy I Price; Michael Cummings
Journal:  Front Psychiatry       Date:  2017-02-13       Impact factor: 4.157

Review 2.  Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.

Authors:  Madhubhashinee Dayabandara; Raveen Hanwella; Suhashini Ratnatunga; Sudarshi Seneviratne; Chathurie Suraweera; Varuni A de Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-22       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.